CIGARETTE SMOKING KILLS; VAPING E-CIGARETTES KILLS, TOO.

This briefing paper provides evidence-based guidance for policy development regarding electronic nicotine delivery systems (ENDS, such as e-cigarettes that heat a nicotine-containing e-liquid or e-juice without tobacco) and heated tobacco products (HTPs, which contain tobacco). It is particularly relevant in the light of at least 215 severe respiratory illnesses and two vaping-related deaths recently reported in the US.1, 2

Despite the rapidly growing evidence of harm, these new products are promoted as supposedly safer alternatives to traditional cigarettes, reminiscent of how tobacco companies promoted cigarette filters3 and “light” or “low tar” cigarettes4 to give false reassurance to smokers that such innovations reduced their risks of health harms. Scientific and historical evidence has exposed these as industry deception.

Currently, Philip Morris International (PMI) admits that “the best choice any smoker can make is to quit cigarettes and nicotine altogether,” but it also says those who don’t quit should shift to ENDS and HTPs.5

Tobacco harm reduction and the 95%-safer factoid

The argument to shift smokers to vaping is what proponents of ENDS and HTPs refer to as tobacco harm reduction, but the European Respiratory Society (ERS) in a May 2019 position paper6 cites various arguments for why a harm reduction strategy shouldn’t be used as a population-based tobacco control strategy. These are echoed in a more recent article7 by Prof. Charlotta Pisinger, Denmark’s leading tobacco control expert and international expert on e-cigarettes, and Prof. Judith Mackay, a globally renowned tobacco control expert recognized by Time Magazine as one of the “most influential people in the world” for her role as a tobacco control campaigner.

To be valid, a tobacco harm reduction strategy should clearly demonstrate that it results in significantly reduced harm and does not itself cause harm. Vaping proponents often argue that ENDS and HTPs are generally harmless, claiming that e-cigarettes are “95% less harmful” than cigarettes and therefore safe to use. They say e-cigarettes only emit steam with “negligible other things,” citing industry studies that reportedly show a 90- to-95-percent reduction in exposure to toxins from e-cigarettes compared to cigarettes. Unfortunately, there is no credible scientific evidence to support such claims. In fact, a few weeks ago, the World Health Organization (WHO) itself declared that e-cigarettes are “undoubtedly harmful” and not a safer alternative to regular cigarettes.8 Only Public Health England (PHE) has said ENDS (not HTPs) are 95% less harmful than cigarettes (note: because they contain tobacco, PHE considers HTPs more harmful than ENDS but does not attempt to quantify their level of harm). The Israel Cancer Association has openly criticized PHE’s “95% less harmful” claim.910

The 95%-safer factoid, first cited by PHE in 2015, was already debunked by an analysis11 in the British Medical Journal. It is based on a single paper by Nutt et al.12, who reported this figure based on the opinion of a small group of experts, who themselves acknowledged in their paper that there was a “lack of hard evidence for the harms of most products on most of the criteria” and that “there was no formal criterion for the recruitment of the experts.” In the words of an editorial13 of the prestigious medical journal, The Lancet, “the opinions of a small group of individuals with no pre-specified expertise in tobacco control were based on an almost total absence of evidence of harm.” Also, the study by Nutt et al. was funded by Euroswiss Health, which has links to the tobacco industry, and Lega Italiana Anti Fumo (LIAF), which funds the e-cigarette research of one of Nutt’s co-authors, Riccardo Polosa, who also has ties to the tobacco industry. Polosa is past President and currently Chief Scientific Advisor to LIAF and serves as a consultant to an e-cigarette distribution company. The journal editors added a note at the end of the paper about the “potential conflict of interest” associated with this work. While more studies have been conducted since 2015, there remains no independent study that quantifies the degree of “less harm” of these new products.

In contrast, the World Health Organization, Philippine Department of Health, Philippine Medical Association, Philippine Pediatric Society, National Cancer Society of Malaysia, Indian Ministry of Health and Family Welfare, Indian Council of Medical Research, Australian Government’s National Health and Medical Research Council, Australian Medical Association, Royal Australasian College of Physicians European Public Health Association, European Respiratory Society, Irish Heart Foundation, Irish Cancer Society, Israel Cancer Association, Turkish Medical Association, Turkish Green Crescent Society, American Medical Association, American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians, American College of Obstetricians and Gynecologists, American Heart Association, American Lung Association, and various other national and international governmental and non-governmental organizations have examined the available evidence and decided to take a precautionary approach with regard to ENDS and HTPs.

More than 40 countries14 have already banned the sale of e-cigarettes/ENDS and emerging tobacco products such as HTPs. Among these are five ASEAN countries: Brunei , Cambodia, Lao PDR, Singapore, and Thailand. Others include Argentina, Australia, Brazil, East Timor, Kuwait, Taiwan, UAE, and Uruguay. India and Hong Kong are also considering a ban on these products.

Vaping: a cocktail of toxic and unknown chemicals, not just water vapor

Contrary to the misleading perception that ENDS and HTPs only generate steam or water vapor, these products actually emit chemical aerosols (smoke is also a chemical aerosol) composed of particulate matter suspended in gas. Even if temperatures applied are lower than in conventional cigarettes, heating e-liquids and/or tobacco results in pyrolysis or thermal decomposition without combustion and creates many of the same toxic chemicals found in cigarette smoke, and because there is a non-linear dose-response relationship between exposure and health risks, it remains unproven that lower exposure will equate to reduced risks or reduced harm. Because tobacco is inherently toxic and contains carcinogens even in its natural form, the WHO has warned that all forms of tobacco, including HTPs, are harmful, and that there is no evidence to demonstrate that HTPs are less harmful than conventional tobacco products.15 Independent research on HTPs, including analysis of Philip Morris International’s (PMI) own data submitted to the US Food and Drug Administration (FDA) on its flagship HTP, IQOS, has shown that HTPs release the same harmful constituents of conventional tobacco cigarette smoke, such as volatile organic compounds (VOCs), polycyclic aromatic hydrocarbons (PAHs), and carbon monoxide,16 and that while lower levels of some toxicants are delivered by HTPs compared to conventional cigarettes, there is no evidence to show that lower exposure results in lower risks of harm in humans as demonstrated by biomarkers and lung function in smokers that switched to IQOS. 17, 18 A new study published earlier this year showed HTPs, ENDS, and conventional cigarettes are all toxic to human lung cells.19

Note also that PMI reported levels for only 40 of the 93 harmful and potentially harmful constituents (HPHC) in the US FDA’s list, and of the 53 not tested, 50 are carcinogens. In addition, levels of 56 other constituents, which are not included in the PMI or FDA lists of HPHCs, were higher in IQOS emissions; 22 were >200% higher and seven were >1,000% higher than in a standard cigarette’s smoke, some of which are potentially toxic, while others have still undetermined effects.20

For these reasons, the US FDA’s Tobacco Products Scientific Advisory Committee rejected PMI’s claim that its IQOS HTP demonstrated any modified (reduced) health risk,21 and while the US FDA has permitted sale of IQOS in the US, it has clarified that this does not mean these products are safe or “FDA approved” or that PMI can legally make claims that IQOS is a modified risk tobacco product (MRTP).22

Similarly, ENDS aerosols include fine particulate matter (PM 2.5),23 as well as glycols, aldehydes, volatile organic compounds (VOCs), polycyclic aromatic hydrocarbon (PAHs), tobacco-specific nitrosamines (TSNAs), toxic metals (lead, nickel, and chromium),24, 25 silicate particles and other elements. Dicarbonyls (glyoxal, methylglyoxal, diacethyl) and hydroxycarbonyls (acetol) also are thought to be important compounds in the aerosol. Many of these substances are toxicants that have known health effects resulting in a range of significant pathological changes.”26, 27

Available animal and human studies and reports have identified serious health risks and actual health harms of ENDS liquids, flavors, aerosols, and solvents;28 these include damage to cellular DNA,29, 30 blood vessels,31 lung cells,32, 33, 34, 35, 36, 37 and brain stem cells,38 as well as cancer,39 asthma,40 acute respiratory distress,41, 42 other acute and chronic lung disorders,43, 44, 45 mouth and teeth disorders,46 and seizures.47 The US FDA and US Centers for Disease Control and Prevention (CDC) are currently investigating the role of e-cigarettes in some of these serious diseases.

Aside from nicotine, the ingredients of e-juice are propylene glycol, vegetable glycerin, and flavorings, which vapers claim are harmless and even approved (“generally recognized as safe”) for use in food. Unfortunately, this oversimplification fails to recognize that food-grade substances are not approved for inhalation, and the long-term effects of inhaling these substances and the by-products created by heating them are still largely unknown.

More than 15,500 unique e-liquid flavors were identified as available on the market in 2016-2017,48 double the number from three years prior. 49 It is currently impossible to determine the health impacts of each flavor or combinations of flavors, but certain common flavoring chemicals used and found in e-liquids with and without nicotine have already been identified to be cytotoxic, particularly diacetyl (which is a cause of bronchiolitis obliterans or “popcorn lung”), cinnamaldehyde, vanillin, pentanedione, and acetoin, with increased toxicity noted for combinations of flavors.50, 51, 52 Researchers have also identified e-liquids as chemically unstable, with reactions occurring between flavorant and solvent components and forming new compounds after mixing and during storage of e-liquids.53, 54

Nicotine: addiction, disease, and toxicity

Nicotine in itself is not a benign substance; in addition to its being highly addictive, it increases the risk of cardiovascular, respiratory, gastrointestinal, and reproductive and perinatal disorders, suppresses the immune response, and plays a clear role in carcinogenesis through cell proliferation, oxidative stress, apoptosis, and DNA mutation, as well as tumor growth, metastasis, and chemoresistance.55 It has been shown to impair adolescent brain maturation with short-term and potentially severe long-term consequences for teen addiction, cognition, and emotional regulation.56, 57 Very recently, a 22-year-old man sued Juul Labs for his severe nicotine addiction (a Juul pod contains as much nicotine as a pack of cigarettes) that caused a massive hemorrhagic stroke, which required three brain surgeries and left him with permanent paralysis, speech impairment, and visual loss.58

Nicotine is also a highly potent poison. With growing e-cigarette use, more than 2,600 cases of nicotine poisoning, both accidental (mostly among young children) and intentional (among teens and adults), have been reported in recent years, mostly in the US, but also in Canada, South Korea, and 17 EU member states.59,60,61 Of these cases, at least 11 resulted in death.62

Disturbingly, 25.7% of US 12th graders believed they were vaping “just flavors” and did not know there was nicotine in their e-liquids.63

E-cigarette fires and explosions: physical injuries and deaths

On top of chemical toxicity, faulty vaping devices have also caused fires and explosions resulting in property damage and serious physical injuries (e.g. leg, hand, neck, and facial burns, other facial (eye, nose, mouth) trauma, and skull and neck fractures).64, 65 One such case in the Philippines, involving a 17- year-old was reported in 2018.66, 67 In the US alone from 2015 to 2017, there were an estimated 2,035 e-cigarette explosion and burn injuries presenting to US hospital emergency departments.68

At least two deaths have been documented in the US due to exploding e-cigarettes. The first such death was of a 38-year-old man, an experienced vaper, whose vape pen was made by a Cebu-based company.69 Earlier this year, a 24-year-old man was killed by his newly bought e-cigarette.70

Secondhand vaping

Given the chemical profile of ENDS and HTP aerosols, there is a potential risk of harm from secondhand exposure, even when emissions are not clearly visible. Both the WHO and US National Academies of Sciences, Engineering, and Medicine (NASEM) have determined that there is conclusive evidence that exhaled e-cigarette aerosols increase airborne concentrations of particulate matter, nicotine, and some toxicants compared with background levels.71, 72 While very limited studies have examined the health risks of passive exposure to e-cigarette aerosols, a systematic review of evidence concluded that passive exposure to the air pollutants in ENDS aerosols is at concentrations associated with potential adverse health effects.73, 74 More recent studies indicate the potential for secondhand exposure to ENDS aerosols to exacerbate asthma among youths,75 as well as induce cough, nausea/vomiting, throat and respiratory irritation or acute nicotine toxicity among children and adolescents.76

It is therefore logical and appropriate that the WHO77 and indoor air experts78, 79 have recommended that vaping be banned in places where smoking is banned. American Society of Heating, Refrigerating and Air Conditioning Engineers (ASHRAE) Standard 62.180 includes e-cigarette emissions in its definition of environmental tobacco smoke.81

E-cigarettes sustain nicotine addiction: not a proven smoking cessation tool

The harm reduction argument also tells smokers that they’re incapable of quitting, and the ERS position paper is quick to state that it’s based on an incorrect premise that smokers can’t or won’t quit smoking. In reality, majority of smokers want to quit, many of whom dislike being nicotine dependent and want to end their nicotine addiction. Worldwide, millions of smokers have quit with only social and behavioral support and without the use of nicotine replacement therapy (NRT) or any smoking cessation medication. Alternative nicotine-delivery products, such as e-cigarettes and HTPs, by rapidly delivering nicotine to the brain similarly to cigarettes, help to sustain rather than break nicotine addiction. A recent study among highly educated young adults even suggests that e-cigarettes are more addictive than conventional cigarettes.82 Encouraging smokers to shift to vaping is tantamount to giving up on them. Instead, governments should be promoting tobacco cessation and relapse prevention to help smokers achieve long-term abstinence and freedom from nicotine addiction.

While some vaping proponents argue that vaping is an effective smoking cessation tool, even manufacturers of ENDS83 and HTPs state that their products are switching products (from smoking conventional cigarettes to smoking electronic ones) and not intended to be smoking cessation products. IQOS is an acronym for “I quit ordinary smoking,” indicating that the user is still smoking, albeit not regular cigarettes, and this was indeed the intention of its manufacturer: to keep people smoking. As one PMI salesman of IQOS put it, “It’s not designed to help stop people from smoking. It’s designed to be a replacement.”84

Some smokers say vaping helped them quit smoking cigarettes, but studies show that e-cigarette use does not necessarily lead to greater quitting or reduced consumption85 but has dampened or hindered smoking cessation at a population level8687 through dual use (alternating between cigarettes and e-cigarettes) or transitioning to vaping without quitting;88, 89, 90, 91, 92 while triple use (cigarettes, ENDS and HTPs) has even been reported among young South Korean adults using HTPs.93 Even in the UK where e-cigarette use is heavily promoted, a 2006-2016 time series study94 to assess the population-level impact of the use of NRT and e-cigarettes for harm reduction on cigarette consumption concluded that “if use of e-cigarettes and licensed NRT while smoking acted to reduce cigarette consumption in England between 2006 and 2016, the effect was likely very small at a population level.” This means that other tobacco control measures are responsible for the continuing decline of smoking in the UK.

Gateway to smoking and other drug use

Evidence95, 96, 97 is growing that vaping predicts future cigarette experimentation. Many ENDS devices are also used for vaping marijuana and other drugs.98

Preventing youth uptake

Everyone agrees how important it is that youths should not be smoking or vaping. Even tobacco companies have said so publicly for decades, although they said otherwise in private. Internal tobacco company documents clearly show that they targeted teenagers, referred to 14-to-18-year-olds as “young adult smokers,” studied teen smoking patterns (differentiating between “presmokers”, “learners” and “confirmed smokers”), admitted that “the base of our business is the high school student,”99 recognized that “the renewal of the market stems almost entirely from 18-year-old smokers”100 and that “today’s teenager is tomorrow’s potential regular customer,”101 and concluded that “the ability to attract new smokers and develop them into a young adult franchise is key to brand development.”102 In order to survive and prosper over the long term, tobacco companies have seen the need to capture the youth market, developing new products and brands that appeal to youths, because “younger adult smokers are the only source of replacement smokers… If younger adults turn away from smoking, the industry must decline, just as a population which does not give birth will eventually dwindle.”103

Regardless of what manufacturers say, it would be naive to believe that these new products aren’t designed to be attractive to youths or non-smokers, even while appealing to current smokers. Conventional cigarettes allegedly aren’t designed or intended to attract youths and new smokers either, but, despite stringent regulations against underage sales, teen smokers are still able to obtain and use them. In December 2018, the US Surgeon General declared an epidemic of e-cigarette use among American youths after e-cigarette use increased 78% among high school students during the past year, from 11.7% in 2017 to 20.8% in 2018.104

Youths are naturally curious and want to try new things, especially sleek and hi-tech gadgets (which e-cigarettes are designed to be), and they’re more open to taking risks, which are aggressively downplayed in the case of vaping. For example, according to former US FDA commissioner Dr. David Kessler, “Juul says it doesn’t target kids, but its e-cigarettes pull them in, [because] the design makes it easier for young people to use.”105 Further, ENDS and HTPs, especially those using nicotine salts (pioneered by Juul), have succeeded in reducing nicotine’s irritation and harshness to the throat and created a smoother and more potent/addictive nicotine-laced aerosol for new users.

The use of vape flavors is also borrowed from the tobacco industry playbook: “It’s a well-known fact that teenagers like sweet products. Honey might be considered.”106 Examples of honey-flavored e-juice are honey graham, honey milk, milk and honey, honey creme, honeycomb berry, and organic honey. Fruit and candy flavors are also popular and attract new users, including youths, and reinforce the misperception that these products are “safe”.

Regulating ENDS and HTPs

Given that there is no evidence of long-term safety of these products, the precautionary principle should apply when regulating them. At one end of the regulatory spectrum is prohibiting the manufacture, promotion, distribution, sale, and use of ENDS and HTPs, which more than 40 countries have done. This is a logical approach, particularly where the regulatory framework or enforcement may be weak or problematic.

Some jurisdictions have opted to regulate these products by restricting their manufacture, promotion, distribution, sale, and use. HTPs, by virtue of their being tobacco products, should be subject to the same policy and regulatory measures as for all other tobacco products, as recommended by the WHO107 and in line with the WHO Framework Convention on Tobacco Control (FCTC).108 ENDS, being similar to tobacco products, are regulated as tobacco products in at least 18 countries, while at least 29 countries regulate ENDS as pharmaceutical products.109

When regulated as tobacco products, restrictions include prohibiting their use in public places to protect people from secondhand exposure to ENDS and HTP emissions, advertising and promotion bans to reduce uptake by youths, and packaging and health warning requirements. For example, pictorial health warnings are required on all tobacco packages, including HTPs and ENDS, in South Korea (50% of the front and back of packaging of e-juice or liquid nicotine bottle),110 Tajikistan (75% of the front and back of all tobacco product packaging including e‐cigarette packaging),111 and New Zealand (75% of the front and 100% of the back of the package plus standardized packaging for all tobacco products, including HTPs).

Conclusions

E-cigarettes are not harmless and can kill people. Whether they are less harmful and how much less harmful compared to cigarettes is still undetermined. E-cigarette devices and their use are attractive even to youths. While strengthening proven tobacco control measures to help smokers quit, strong precautions must be taken to prevent a new epidemic.

[Updated 5 September 2019]

About SEATCA

SEATCA is a multi-sectoral non-governmental alliance promoting health and saving lives by assisting ASEAN countries to accelerate and effectively implement the evidence-based tobacco control measures contained in the WHO FCTC. Acknowledged by governments, academic institutions, and civil society for its advancement of tobacco control movements in Southeast Asia, the WHO bestowed on SEATCA the World No Tobacco Day Award in 2004 and the WHO Director-General’s Special Recognition Award in 2014.

 

_______________________________

 

 

1 Coldewey, D. (2019). Vape lung has claimed its first victim, and the CDC is investigating. TechCrunch.com, 24 August. Available at: https://techcrunch.com/2019/08/23/vape-lung-has-claimed-its-first-victim-and-the-cdc-is-investigating/
2 Edwards E. (2019). A second possible vaping-related death is under investigation in Oregon [news report]. NBC News, 5 September. Available at: https://www.nbcnews.com/health/vaping/second-possible-vaping-related-death-underinvestigation-oregon-n1049581
3 Harris, B. (2011). The intractable cigarette ‘filter problem’. Tob Control 20:i10-i16. Available at: https://tobaccocontrol.bmj.com/content/20/Suppl_1/i10
4 Leavell, N. (1999). The low tar lie. Tob Control 8:433-437. Available at: https://tobaccocontrol.bmj.com/content/8/4/433
5 Philip Morris International. (2019). Unsmoke your world [website]. Available at: https://www.unsmokeyourworld.com
6 European Respiratory Society. ERS Position paper on tobacco harm reduction, May 2019. Available at: https://www.erseducation.org/Media/Media.aspx?idMedia=417874
7 Pisinger C and Mackay J. (2019). New tobacco products do not protect public health. Annals of the American Thoracic Society. DOI: https://doi.org/10.1513/AnnalsATS.201905-411PS
8 World Health Organization. (2019). WHO Report on the Global Tobacco Epidemic, 2019. Geneva: World Health Organization.
9 Epstein S. (2019). Israel Cancer Association slams e-cigarettes, backs WHO report. The Jerusalem Post, 29 July. Available at: https://www.jpost.com/Israel-News/Israel-Cancer-Association-slams-e-cigarettes-backs-WHO-report-597076
10 Siegel-Itzkovich, J. (2019). British and Israeli health experts warn about ‘fake news’ on electronic cigarettes. Breaking Israel News, 15 May. Available at: https://www.breakingisraelnews.com/128908/british-israeli-health-experts-electroniccigarettes/
11 McKee M and Capewell S. (2015). Evidence about electronic cigarettes: a foundation built on rock or sand? BMJ 351:h4863 doi: 10.1136/bmj.h4863
12 Nutt DJ, Phillips LD, Balfour D, et al. (2014). Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 20(5):218-25. doi: 10.1159/000360220.
13 E-cigarettes: Public Health England’s evidence-based confusion [editorial]. (2015). The Lancet. DOI: https://doi.org/10.1016/S0140-6736(15)00042-2
14 Global Center for Good Governance in Tobacco Control. (2019). E-cigarette ban & regulation: Global status as of June 2019. Available at: https://ggtc.world/dmdocuments/Countries%20that%20Ban%20Ecigs_June2019.pdf
15 World Health Organization. (2018). Heated tobacco products (HTPs) [information sheet], May 2018. Available at: https://apps.who.int/iris/bitstream/handle/10665/272875/WHO-NMH-PND-17.6-eng.pdf
16 Auer R, Concha-Lozano N, Jacot-Sadowski I, et al. (2017). Heat-not-burn tobacco cigarettes: Smoke by any other name. JAMA Intern Med. doi:10.1001/jamainternmed.2017.1419
17 Glantz SA. (2018). PMI’s own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes. Tob Control 2018;27:s9–s12. Available at: http://dx.doi.org/10.1136/tobaccocontrol-2018-054413
18 Moazed F, Chun L, Matthay MA, et al. (2018). Assessment of industry data on pulmonary and immunosuppressive effects of IQOS. Tob Control 2018;27:s20–s25. doi:10.1136/tobaccocontrol-2018-054296
19 Sohal, S.S., Eapen, M.S, Naidu, V.G.M., and Sharma, P. IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette. ERJ Open Research 5 (1): 00159-2018. DOI: 10.1183/23120541.00159-2018
20 St. Helen G, Jacob III P, Nardone N, et al. (2018). IQOS: examination of Philip Morris International’s claim of reduced exposure. Tob Control 2018;27:s30–s36. doi:10.1136/tobaccocontrol-2018-054321
21 Reuters. (2018). US panel rejects Philip Morris claim iQOS tobacco device cuts disease risk. The Guardian, 25 January. Available at: https://www.theguardian.com/us-news/2018/jan/25/us-panel-rejects-philip-morris-claim-iqos-tobacco-devicecuts- disease-risk
22 U.S. Food and Drug Administration. (2019). FDA permits sale of IQOS Tobacco Heating System through premarket tobacco product application pathway [news release, 30 April]. Available at: https://www.fda.gov/news-events/pressannouncements/ fda-permits-sale-iqos-tobacco-heating-system-through-premarket-tobacco-product-application-pathway
23 FernaÅLndez, E., Ballbe`, M., Sureda, X. et al. (2015). Particulate matter from electronic cigarettes and conventional cigarettes: A systematic review and observational study. Curr Envir Health Rpt 2: 423. https://doi.org/10.1007/s40572-015- 0072-x
24 Olmedo P, Goessler W, Tanda S, et al. (2018). Metal Concentrations in e-Cigarette Liquid and Aerosol Samples: The Contribution of Metallic Coils. Environmental Health Perspectives, Vol. 126, No. 2. Available at: https://doi.org/10.1289/EHP2175.
25 Dunbar ZR, Das A, O’Connor RJ, et al. (2018). Brief Report: Lead Levels in Selected Electronic Cigarettes from Canada and the United States. Int J Environ Res Public Health 15(1):154. doi:10.3390/ijerph15010154
26 World Health Organization. (2016). Electronic nicotine delivery systems and electronic non-nicotine delivery systems (ENDS/ENNDS): Report by WHO. Available at: https://www.who.int/fctc/cop/cop7/FCTC_COP_7_11_EN.pdf
27 Son Y, Mishin V, Laskin JD, et al. (2019). Hydroxyl Radicals in E-Cigarette Vapor and E-Vapor Oxidative Potentials under Different Vaping Patterns. Chem Res Toxicol 32(6):1087-1095. Available at: https://doi.org/10.1021/acs.chemrestox.8b00400
28 Son Y. (2018). Estimating the human health risks associated with exposures to harmful constituents emitted from electronic cigarettes [dissertation]. Rutgers, The State University of New Jersey. Available at: https://doi.org/doi:10.7282/T34M97S5
29 Ganapathy V, Manyanga J, Brame L, et al. (2017) Electronic cigarette aerosols suppress cellular antioxidant defenses and induce significant oxidative DNA damage. PLOS ONE 12(5): e0177780. https://doi.org/10.1371/journal.pone.0177780
30 Behar RZ, Wang Y, Talbot P. (2018). Comparing the cytotoxicity of electronic cigarette fluids, aerosols and solvents. Tob Control 2018;27:325–333. doi:10.1136/tobaccocontrol-2016-053472
31 Putzhammer R, Doppler C, Jakschitz T, Heinz K, et al. (2016). Vapours of US and EU market leader electronic cigarette brands and liquids are cytotoxic for human vascular endothelial cells. PLoS ONE 11(6):e0157337. doi:10.1371/journal.pone.0157337
32 Lerner CA, Sundar IK, Yao H, et al. (2015). Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 10(2):e0116732. doi: 10.1371/journal.pone.0116732
33 Larcombe AN, Janka MA, Mullins BJ, et al. (2017). The effects of electronic cigarette aerosol exposure on inflammation and lung function in mice. American journal of physiology-Lung cellular and molecular physiology 313(1):L67-l79. doi: 10.1152/ajplung.00203.2016
34 Garcia-Arcos I, Geraghty P, Baumlin N, et al. (2016). Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 71(12):1119-29. doi: 10.1136/thoraxjnl-2015-208039
35 Wu Q, Jiang D, Minor M, et al. (2014). Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 9(9):e108342. doi: 10.1371/journal.pone.0108342
36 Hwang JH, Lyes M, Sladewski K, et al. (2016). Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. Journal of molecular medicine (Berlin, Germany) 94(6):667- 79. doi: 10.1007/s00109-016-1378-3
37 Reidel B, Radicioni G, Clapp PW, et al. (2018). E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med 197(4):492–501. doi:10.1164/rccm.201708-1590OC
38 Zahedi A., Phandthong R., Chaili A. et al. (2019). Mitochondrial stress response in neural stem cells exposed to electronic cigarettes. iScience 16, 250–269. Available at: https://doi.org/10.1016/j.isci.2019.05.034
39 Canistro D, Vivarelli F, Cirillo S, et al. (2017). E-cigarettes induce toxicological effects that can raise the cancer risk. Scientific Reports 7: 2028. DOI:10.1038/s41598-017-02317-8
40 Clapp PW and Jaspers I. (2017). Electronic cigarettes: Their constituents and potential links to asthma. Curr Allergy Asthma Rep (2017) 17: 79. DOI 10.1007/s11882-017-0747-5
41 Agustin M, Yamamoto M, Cabrera F, and Eusebio R. (2018). Diffuse alveolar hemorrhage induced by vaping. Case Reports in Pulmonology, vol. 2018, Article ID 9724530. https://doi.org/10.1155/2018/9724530.
42 Sun LH. (2019). He went from hiking enthusiast to ‘on death’s door’ within days. Doctors blamed vaping. The Washington Post, 25 August. Available at: https://beta.washingtonpost.com/health/one-mans-near-death-experience-withvaping-related-lung-failure/2019/08/24/ca8ce42c-c5b4-11e9-9986-1fb3e4397be4_story.html?noredirect=on#commentswrapper
43 Palamidas A, Tsikrika S, Katsaounou PA, et al. (2017). Acute effects of short term use of e-cigarettes on airways physiology and respiratory symptoms in smokers with and without airways obstructive diseases and in healthy non-smokers. Tobacco Prevention & Cessation 3(5):1-8.
44 Staudt MR, Salit J, Kaner RJ, et al. (2018). Altered lung biology of healthy never smokers following acute inhalation of Ecigarettes. Respiratory research 19(1):78. doi: 10.1186/s12931-018-0778-z
45 Perez MF, Atuegwu N, Mead E, et al. (2018). E-cigarette use is associated with emphysema, chronic bronchitis and COPD. Poster presented at American Thoracic Society 2018 International Conference; May 18-23, 2018; San Diego, CA. Abstract available at: https://www.abstractsonline.com/pp8/#!/4499/presentation /19432
46 Froum S and Neymark A. (2019). Vaping and oral health: It’s worse than you think. Available at: https://www.perioimplantadvisory.com/clinical-tips/article/16412201/vaping-and-oral-health-its-worse-than-you-think
47 Azad A. (2019). FDA investigating 127 reports of seizures, neurological symptoms related to vaping [news report, 7 August]. CNN.com. https://edition.cnn.com/2019/08/07/health/ecigarette-seizure-fda-investigation/index.html
48 Hsu G, Sun JY, and Zhu SH. (2018). Evolution of electronic cigarette brands from 2013-2014 to 2016-2017: Analysis of brand websites. J Med Internet Res 20(3):e80. DOI: 10.2196/jmir.8550
49 Zhu S-H, Sun JY, Bonnevie E, et al. (2014). Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 23:iii3–iii9. doi:10.1136/tobaccocontrol-2014-051670
50 Muthumalage T, Prinz M, Ansah KO, et al. (2018). Inflammatory and oxidative responses induced by exposure to commonly used e-cigarette flavoring chemicals and flavored e-liquids without nicotine. Front Physiol 8:1130. doi: 10.3389/fphys.2017.01130
51 Allen JG, Flanigan SS, LeBlanc M, et al. (2016). Flavoring chemicals in e-cigarettes: diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Perspect 124:733–739; http://dx.doi.org/10.1289/ehp.1510185
52 Son Y. (2018). Estimating the human health risks associated with exposures to harmful constituents emitted from electronic cigarettes [dissertation]. Rutgers, The State University of New Jersey. Available at: https://doi.org/doi:10.7282/T34M97S5
53 Erythropel HC , Jabba SV, DeWinter TM, et al. (2018). Formation of flavorant–propylene glycol adducts with novel toxicological properties in chemically unstable e-cigarette liquids. Nicotine & Tobacco Research, 2018, 1–11. doi:10.1093/ntr/nty192
54 Erythropel, HC, Davis LM, DeWinter TM, et al. (2019). Flavorant–solvent reaction products and menthol in Juul ecigarettes and aerosol. Am J Prev Med DOI: https://doi.org/10.1016/j.amepre.2019.04.004
55 Mishra A, Chaturvedi P, Datta S, et al. (2015). Harmful effects of nicotine. Indian Journal of Medical and Paediatric Oncology. DOI: 10.4103/0971-5851.151771
56 Goriounova, N. A., & Mansvelder, H. D. (2012). Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harbor perspectives in medicine, 2(12), a012120. doi:10.1101/cshperspect.a012120
57 Yuan, M., Cross, S. J., Loughlin, S. E., & Leslie, F. M. (2015). Nicotine and the adolescent brain. The Journal of physiology, 593(16), 3397–3412. doi:10.1113/JP270492
58 Cai K. (2019). Teen’s two-pod a day Juul addiction caused massive stroke, lawsuit says. Forbes, 18 July. Available at: https://www.forbes.com/sites/kenrickcai/2019/07/18/teen-two-pod-a-day-juul-addiction-caused-massive-stroke-lawsuitvaping- e-cigarettes
59 Payne D, Michaels D, Orellana-Barrios M, and Nugent K. (2017). Electronic cigarette toxicity. Journal of Primary Care & Community Health 2017, Vol. 8(2): 100-102. DOI: 10.1177/2150131916668645
60 Vardavas CI, Girvalaki C, Filippidis FT, et al. (2017). Characteristics and outcomes of e-cigarette exposure incidents reported to 10 European poison centers: a retrospective data analysis. Tob Induc Dis 15:36. DOI 10.1186/s12971-017-0141-z
61 Maessen GC, Wijnhoven AM, Neijzen RL, et al. (2019). Nicotine intoxication by e-cigarette liquids: a study of case reports and pathophysiology. Clinical Toxicology, DOI: 10.1080/15563650.2019.1636994
62 Maessen GC, Wijnhoven AM, Neijzen RL, et al. (2019). Nicotine intoxication by e-cigarette liquids: a study of case reports and pathophysiology. Clinical Toxicology, DOI: 10.1080/15563650.2019.1636994
63 Miech RA, Johnston LD, O’Malley PM, et al. (2018). Monitoring the Future: national survey results on drug use, 1975-2017. Vol. I. Secondary school students. Ann Arbor: University of Michigan Institute for Social Research. Available at: http://monitoringthefuture.org/pubs/monographs/mtf-vol1_2017.pdf.
64 McKenna Jr., LA. (2017). Electronic cigarette fires and explosions in the United States 2009–2016. Research Group, National Data Fire Center, United States Fire Administration, U.S. Department of Homeland Security. Available at: https://www.usfa.fema.gov/downloads/pdf/publications/electronic_cigarettes.pdf
65 Kaplan S. (2019). E-cigarette exploded in a teenager’s mouth, damaging his jaw. The New York Times, 19 June. Available at: https://www.nytimes.com/2019/06/19/health/ecigarettes-explosion.html
66 De Vera A. (2018). DOH to probe alleged explosion of vaping device wounding face of 17-year-old boy. Manila Bulletin, 4 November. Available at: https://news.mb.com.ph/2018/11/04/doh-to-probe-alleged-explosion-of-vaping-device-woundingface- of-17-year-old-boy/
67 GMA News. (2018). 24 Oras: Binatilyo, nasabugan ng vape sa bibig. Available at: https://www.youtube.com/watch?v=wWtKBunjtgY
68 Rossheim ME, Livingston MD, Soule EK, et al. (2019). Electronic cigarette explosion and burn injuries, US Emergency Departments 2015–2017. Tob Control 28:472-474. Available at: http://dx.doi.org/10.1136/tobaccocontrol-2018-054518
69 Brodwin E. (2018). A vape pen killed a 38-year-old man — and it’s a type of e-cig that’s wildly popular among one group of vapers. Business Insider, 17 May. Available at: https://www.businessinsider.com/vape-pen-explosion-kills-florida-man-ecig- type-brand-2018-5
70 Beasley Allen Law Firm. (2019). E-cigarette explosion kills Texas man. Published February 5, 2019. Available at: https://www.beasleyallen.com/news/e-cigarette-explosion-kills-texas-man/.
71 World Health Organization. (2014). Electronic nicotine delivery systems: Report by WHO. Available at: http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf
72 National Academies of Sciences, Engineering, and Medicine. (2018). Public health consequences of e-cigarettes. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/24952.
73 Hess IMR, Lachireddy K, & Capon A. (2016). A systematic review of the health risks from passive exposure to electronic cigarette vapour. Public Health Res Pract 26(2):e2621617. doi: http://dx.doi.org/10.17061/phrp2621617
74 National Academies of Sciences, Engineering, and Medicine. (2018). Public health consequences of e-cigarettes. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/24952.
75 Bayly JE, Bernat D, Porter L, et al. (2019). Secondhand exposure to aerosols from electronic nicotine delivery systems and asthma exacerbations among youth with asthma. Chest 155(1):88-93. doi: 10.1016/j.chest.2018.10.005
76 Richmond, S. A., Pike, I., Maguire, J. L., & Macpherson, A. (2018). E-cigarettes: A new hazard for children and adolescents. Paediatrics & child health, 23(4), 255–259. doi:10.1093/pch/pxx204
77 World Health Organization. (2016). Electronic nicotine delivery systems and electronic non-nicotine delivery systems (ENDS/ENNDS): Report by WHO. Available at: https://www.who.int/fctc/cop/cop7/FCTC_COP_7_11_EN.pdf
78 Offermann FJ. (2014). The hazards of e-cigarettes. ASHRAE Journal, June 2014. Available at: http://www.asat.org.ar/images/comunidad/publicaciones/2014june_038-047_iaq_offerman_rev.pdf
79 Repace JL. (2017). Testimony of James L. Repace on MD House of Delegates Bill 354, Clean Indoor Air Act – Use of Electronic Cigarette Devices – Prohibition. Available at: https://www.researchgate.net/publication/313561725_Testimony_of_James_L_Repace_on_MD_House_of_Delegates_Bill_354_Clean_Indoor_Air_Act_-_Use_of_Electronic_Cigarette_Devices_-_Prohibition
80 American Society of Heating, Refrigerating and Air Conditioning Engineers. (2016). ASHRAE Standard 62.1-2016: Ventilation for acceptable indoor air quality. Atlanta: ASHRAE. Available at: https://www.ashrae.org/technicalresources/bookstore/standards-62-1-62-2
81 ASHRAE. (undated). Environmental Health Committee (EHC) emerging issue brief: Electronic nicotine delivery systems (ENDS) in indoor environments, also known as e-cigs / e-cigarettes / “Vaping”. Available at: https://www.ashrae.org/File%20Library/Communities/Committees/Standing%20Committees/Environmental%20Health%20Committee%20(EHC)/EHC-Emerging-Issue—Electronic-Nicotine-Delivery-Systems–ENDS–in-Indoor-Environments.pdf
82 Jankowski M, Krzystanek M, Zejda JE, et al. (2019). E-Cigarettes are more addictive than traditional cigarettes—A study in highly educated young people. Int. J. Environ. Res. Public Health 16(13): 2279. Available at: https://doi.org/10.3390/ijerph16132279
83 Juul Labs. (2019). Juul Marketing & Social Media Code. Available at: https://www.juul.com/ourresponsibility# marketing-code
84 Espiner G. (2019). Big Tobacco targeting Māori with e-cigarettes. Radio New Zealand, 11 July. Available at: https://www.rnz.co.nz/news/in-depth/394073/big-tobacco-targeting-maori-with-e-cigarettes?
85 Grana RA, Popova L, and Ling PM. (2014). A longitudinal analysis of e-cigarette use and smoking cessation. JAMA Intern Med 174(5): 812–813. doi:10.1001/jamainternmed.2014.187.
86 Glantz SA and Kalkhoran S. (2016). E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 4: 116–28. Available at: http://dx.doi.org/10.1016/S2213-2600(15)00521-4
87 Kulik MC, Lisha NE, & Glantz SA. (2018). E-cigarettes associated with depressed smoking cessation: A cross-sectional study of 28 European Union countries. Am J Prev Med 54(4): 603-609. https://doi.org/10.1016/j.amepre.2017.12.017
88 Action on smoking and health. Use of e-cigarettes (vapourisers) among adults in Great Britain. Available at: http://ash.org.uk/media-and-news/press-releases-media-and-news/large-national-survey-finds-2-9-million-people-now-vapein-britain-for-the-first-time-over-half-no-longer-smoke/
89 Christensen T, Welsh E, & Faseru B. (2014). Profile of e-cigarette use and its relationship with cigarette quit attempts and abstinence in Kansas adults. PrevMed 69:90-94. doi: 10.1016/j.ypmed.2014.09.005
90 Manzoli L, Flacco ME, Fiore M, et al. (2015). Electronic cigarettes efficacy and safety at 12 months: Cohort study. PLoS ONE 10(6): e0129443. https://doi.org/10.1371/journal.pone.0129443
91 Sung HY, Wang Y, Yao T, et al. (2018). Polytobacco use and nicotine dependence symptoms among US adults, 2012-2014. Nicotine Tob Res 20(suppl_1):S88-s98. doi: 10.1093/ntr/nty050
92 Sweet L, Brasky TM, Cooper S, et al. Quitting behaviors among dual cigarette and e-cigarette users and cigarette smokers enrolled in the Tobacco User Adult Cohort. Nicotine Tob Res 2019;21(3):278-84. doi: 10.1093/ntr/nty222
93 Kim J, Yu H, Lee S, et al. Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults. Tob Control 2018;27(Suppl 1):s74-s77. doi: 10.1136/tobaccocontrol-2018-054390
94 Beard E, Brown J, Michie S, et al. (2018). Is prevalence of e-cigarette and nicotine replacement therapy use among smokers associated with average cigarette consumption in England? A time-series analysis. BMJ Open 8:e016046.doi:10.1136/bmjopen-2017-016046
95 Soneji S, Barrington-Trimis JL, Wills TA, et al. (2017). Association between initial use of e- cigarettes and subsequent cigarette smoking among adolescents and young adults: A systematic review and meta-analysis. JAMA Pediatr, 171(8), 788- 797. doi: 10.1001/jamapediatrics.2017.1488.
96 Miech RA, Patrick ME, O’Malley PM, & Johnston LD. (2017). E- cigarette use as a predictor of cigarette smoking: Results from a 1-year follow-up of a national sample of 12th grade students. Tob Control, 26(e2), e106-e111. doi: 10.1136/tobaccocontrol-2016-053291
97 Berry KM, Fetterman, JL, Benjamin EJ, et al. (2019). Association of electronic cigarette use with subsequent initiation of tobacco cigarettes in US youths. JAMA Network Open 2(2):e187794.doi:10.1001/jamanetworkopen.2018.7794
98 Breitbarth AK, Morgan J, Jones AL. (2018). E-cigarettes—An unintended illicit drug delivery system. Drug and Alcohol Dependence 192: 98-111. Available at: https://doi.org/10.1016/j.drugalcdep.2018.07.031
99 Achey TL. (1978). Memo from Lorillard sales manager Achey to CEO Curtis Judge about the “fantastic success” of Newport, August 30, 1978. Bates No. TINY0003062
100 R.J. Reynolds. (1984). Young adult smokers: Strategies and opportunities [report]. Bates No. 501928462-8550
101 Johnston ME. (1981). Young smokers prevalence, trends, implications, and related demographic trends [Philip Morris market research report, 31 March 1981]. Bates No. 1000390803
102 Philip Morris International. (1999). Worldwide Marlboro monitor: Five year trends, 1988-1992. Bates No. 2044895379-484
103 R.J. Reynolds. (1984). Young adult smokers: Strategies and opportunities [report]. Bates No. 501928462-8550
104 Cullen KA, Ambrose BK, Gentzke AS, et al. (2018). Notes from the field: Increase in use of electronic cigarettes and any tobacco product among middle and high school students – United States, 2011-2018. MMWR Morbidity & Mortality Weekly Report 67(45):1276-1277.
105 Kessler D. (2019). Juul says it doesn’t target kids. But its e-cigarettes pull them in. The New York Times, 31 July. Available at: https://www.nytimes.com/2019/07/31/opinion/juul-kids.html
106 Marketing Innovations. (1972). Youth cigarette – New concepts [memo to Brown & Williamson]. Bates No. 170042014
107 World Health Organization. (2018). Heated tobacco products (HTPs) [information sheet], May 2018. Available at: https://apps.who.int/iris/bitstream/handle/10665/272875/WHO-NMH-PND-17.6-eng.pdf
108 Conference of Parties to the WHO FCTC. (2018). Novel and emerging tobacco products (Decision FCTC/COP8(22), 6 October 2018). Available at: https://www.who.int/fctc/cop/sessions/cop8/FCTC_COP8(22).pdf
109 WHO FCTC Secretariat. (2018). Progress report on regulatory and market developments on electronic nicotine delivery systems (ENDS) and electronic non-nicotine delivery systems (ENNDS): Report by the Convention Secretariat. Available at: https://www.who.int/fctc/cop/sessions/cop8/ FCTC_COP_8_10-EN.pdf
110 Korea Ministry of Health and Welfare. Pictorial health warning manual, 2018.
111 Law of the Republic of Tajikistan “On Limiting the Use of Tobacco Products”, 2018.